AI assistant
Sending…
Roivant Sciences Ltd. — Director's Dealing 2021
Oct 1, 2021
30587_dirs_2021-10-01_3a038f84-00d1-4c8f-be04-5c25d6a1c84e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2021-10-01
Reporting Person: MANCHESTER KEITH S (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 13908356 | Indirect |
| Common Shares | 30321987 | Indirect |
| Common Shares | 5616260 | Indirect |
| Common Shares | 39778514 | Indirect |
Footnotes
F1: Keith Manchester is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. He disclaims any beneficial ownership in the Roivant Sciences Ltd. common shares described herein, other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
More from Roivant Sciences Ltd.
Regulatory Filings
2026
May 20
Annual Report
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 18